On Monday, Shares of SeaWorld Entertainment Inc (NYSE:SEAS), gained 0.88% to $18.32. 2.34 million shares of the company were exchanged.
SeaWorld Entertainment, Inc. (SEAS) declared that it will review its options in light of the California Coastal Commission’s approval of the Company’s Blue World Project with certain conditions. Those conditions comprise prohibiting breeding or transporting the whales at the facility.
“While we appreciate the opportunity to present the Blue World Project to the Commission, and are happy that the Commission recognizes the benefits of the planned expansion, we are disappointed with the conditions they have placed on their approval,” said Joel Manby, President and Chief Executive Officer of the Company. “Depriving these social animals of the natural and fundamental right to reproduce is inhumane and we do not support this condition.”
Named the Blue World Project because of its size and scope, this first-of-its-kind killer whale environment is planned to have a total water volume of 10 million gallons, nearly double that of the existing facility.
SeaWorld Entertainment, Inc. operates as a theme park and entertainment company in the United States. The company operates marine-life theme park under the SeaWorld brand name in Orlando, San Antonio, and San Diego; Busch Gardens theme parks, which are family-oriented destinations with foreign geographic settings in Tampa and Williamsburg; Discovery Cove marine-life theme park in Langhorne; and Sesame Place, a seasonal park in Langhorne.
Shares of XOMA Corp (NASDAQ:XOMA), declined -0.07% to $0.992, during its last trading session.
In the last trading session, the stock moved on low volume, trading at a volume of 2.00 M as compared to its average daily volume of 5.90 million shares.
The stock, as of recent close, has shown weekly upbeat performance of 2.06% which was maintained at 26.92% in 1-month period.
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate comprises gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta, which is in Phase III clinical trial for NIU and Behçet’s disease uveitis, pyoderma gangrenosum, active non-infectious anterior scleritis, autoimmune inner ear disease, and cardiovascular diseases, in addition to diseases under the neutrophilic dermatoses designation, Schnitzler syndrome, and other diseases; and various proof-of-concept studies comprising polymyositis/dermatomyositis, Schnitzler syndrome, and giant cell arteritis.
At the end of Monday’s trade, Shares of Alcatel Lucent SA (ADR) (NYSE:ALU), declined -0.80% to $3.71.
Alcatel-Lucent (ALU) and BT are to commence an extensive consumer trial of the ultra-broadband access G.fast technology in Gosforth in the north-east of England.
G.fast – in which BT, Alcatel-Lucent and its Bell Labs research arm have played a pioneering development role - allows service providers to provide ultra-broadband Internet speeds in locations where deploying fiber-optic connectivity is difficult. It also eliminates the need to rewire entire buildings and homes, the most costly and time-consuming part of any fiber deployment. During the trial, G.fast will enable data speeds of up to 330 Mbps, delivered over copper infrastructure directly into premises.
Alcatel-Lucent’s G.fast technology has already been in trials with more than 30 operators worldwide. The BT trial will cover up to 2000 homes in Gosforth, near Newcastle-upon-Tyne, and will last for six to nine months. It follows a much smaller but very successful pilot conducted by BT and Alcatel-Lucent around Hethersett in Norfolk, earlier this year.
Alcatel-Lucent provides Internet protocol (IP) and cloud networking, and ultra- broadband access worldwide. The company’s Core Networking segment offers IP routing, carrier Ethernet, network functions virtualization, and software defined networking applications and infrastructure to meet the challenges of network traffic growth while supporting the delivery of cloud-enabled business, mobile, and residential services for service providers, mobile network operators, cable/multiple system operators, transportation, utilities, and large-scale enterprises.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
